Back

Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General

29 August 2022 (16:15 - 16:40)
Organised by:
Congress Presentation Part of: Treatment of atrial fibrillation in patient with coronary artery disease Clinical ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Marco Vitolo

Modena Polyclinic Modena University Hospital, Modena (Italy)

4 More presentations in this session

Presentation thumbnail
Causes of death in patients with atrial fibrillation and a recent acute coronary syndrome or percutaneous coronary intervention: Insights from the AUGUSTUS trial
Professor R. Lopes (Durham, US)
Abstract Slides
Presentation thumbnail
Determinants of post-operative atrial fibrillation in 1613 patients undergoing coronary artery bypass grafting in the Statin Therapy In Cardiac Surgery (STICS) trial
Doctor R. Wijesurendra (Oxford, GB)
Abstract Slides
Presentation thumbnail
Features of clinical complexity in european patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry
Doctor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Screen-detected atrial fibrillation (AF) and 'micro-AF' after myocardial infarction in patients 70-82 years and risk of cardiovascular events in the OMEMI trial
Doctor T. Berge (Baerum, NO)
Abstract Slides

Access the full session

Session thumbnail
Treatment of atrial fibrillation in patient with coronary artery disease

The Event

Event poster

ESC Congress 2022

29 August 2022 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between frailty and all-cause mortality in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational research programme AF general long-term registry
28 August 2020
thumbnail
Congress Presentation
The 3S-AF scheme, rather than the 4S-AF scheme, predicts progression in patients with paroxysmal atrial fibrillation: data from RACE V study
3 April 2022
thumbnail
Congress Presentation
Prognostic implications of a newly onset atrial fibrillation in patients with heart failure and preserved ejection fraction
29 June 2021
thumbnail
Congress Presentation
Management and impact of atrial fibrillation in the COVID 19 era; concomitancy of two procoagulant phenomena
29 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources